Adrenal gland – Adrenocortical adenoma with weak to moderate HMGB1 staining of tumor cells
Adrenal gland – Pheochromocytoma lacking HMGB1 staining in tumor cells
Adrenal gland – Pheochromocytoma with absence HMGB1 staining in tumor cells
Esophagus – Adenocarcinoma showing a strong HMGB1 staining of tumor cells
Esophagus – Squamous cell carcinoma lacking HMGB1 staining in tumor cells
Esophagus – Squamous cell carcinoma with strong HMGB1 staining of tumor cells
Kidney – Chromophobe renal cell carcinoma with a complete loss of HMGB1 staining of tumor cells
Kidney – Chromophobe renal cell carcinoma with strong HMGB1 immunostaining of all tumor cells
Kidney – Clear cell renal cell carcinoma with a complete loss of HMGB1 staining i tumor cells
Kidney – Clear cell renal cell carcinoma with strong HMGB1 staining of all tumor cells
Kidney – Papillary renal cell carcinoma lacking HMGB1 staining in tumor cells
Kidney – Papillary renal cell carcinoma with strong HMGB1 positivity of tumor cells
Liver – Cholangiocellular carcinoma lacking HMGB1 immunostaining in tumor cells
Liver – Cholangiocellular carcinoma with moderate to strong HMGB1 staining of tumor cells
Liver – Hepatocellular carcinoma with moderate to strong HMGB1 staining of tumor cells
Lung – Malignant mesothelioma with only a faint HMGB1 staining of tumor cells
Lymph node – Angioimmunoblastic T-cell lymphoma with absence of HMGB1 positivity in the tumor cells
Oral cavity – Squamous cell carcinoma lacking HMGB1 staining in tumor cells
Oral cavity – Squamous cell carcinoma with moderate intensity HMGB1 staining of tumor cells
Oral cavity – Squamous cell carcinoma with strong HMGB1 immunostaining of tumor cells
Ovary – Clear cell carcinoma showing a complete lack of HMGB1 staining in tumor cells
Ovary – Malignant mixed Mullerian tumor exhibiting a strong HMGB1 staining of tumor cells
Pancreas – Neuroendocrine tumor with strong HMGB1 positivity of tumor cells
Prostate – Adenocarcinoma (Gleason 3+3=6) largely lacking HMGB1 staining of tumor cells
Prostate – Adenocarcinoma (Gleason 5+5=10) lacking HMGB1 staining in tumor cells
Prostate – Adenocarcinoma (Gleason 5+5=10) with strong nuclear and moderate cytoplasmic HMGB1 staining of tumor cells
Prostate – Recurrent adenocarcinoma (Gleason 5+5=10) after hormonal therapy now showing a complete loss HMGB1 staining of tumor cells
Salivary gland – Warthin tumor with strong HMGB1 staining of tumor and inflammatory cells
Soft tissue – Chondrosarcoma largely lacking HMGB1 staining of tumor cells
Soft tissue – Primitive neuroektodermal tumor (PNET) showing intense HMGB1 staining of tumor cells
Soft tissue – Sarcoma NOS largely lacking HMGB1 staining in tumor cells
Soft tissue – Sarcoma NOS showing absence of HMGB1 staining in tumor cells
Soft tissue – Sarcoma NOS with strong HMGB1 immunostaining of tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) with strong nuclear and moderate cytoplasmic HMGB1 staining of tumor cells
Stomach – Gastric adenocarcinoma largely lacking HMGB1 staining in tumor cells
Stomach – Gastrointestinal stromal tumor (GIST) lacking HMGB1 staining of tumor cells
Stomach – Gastrointestinal stromal tumor (GIST) with moderate to strong HMGB1 immunostaining of tumor cells
Testis – Seminoma lacking HMGB1 immunostaining in tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma showing a strong HMGB1 positivity of all tumor cells
Uterus – Leiomyosarcoma with moderate HMGB1 immunostaining of tumor cells
Vulva – Squamous cell carcinoma with largely lacking HMGB1 staining of tumor cells
Vulva – Squamous cell carcinoma with strong HMGB1 staining of tumor cells